Literature DB >> 2449959

Liblomycin, a new analogue of bleomycin.

K Takahashi1, H Ekimoto, S Minamide, K Nishikawa, H Kuramochi, A Motegi, T Nakatani, T Takita, T Takeuchi, H Umezawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2449959     DOI： 10.1016/0305-7372(87)90004-1

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog.

Authors:  R A Newman; Z H Siddik; E L Travis; D Followill; W Ayele; T Burditt; I H Krakoff
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trial.

Authors:  T Yoshida; M Ogawa; K Ota; Y Yoshida; A Wakui; M Oguro; Y Ariyoshi; M Hirano; I Kimura; T Matsuda
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Treatment of cancer with cryochemotherapy.

Authors:  L M Mir; B Rubinsky
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.